Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.31 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.30 |
| ▸ | WNT3A | P56704 | 1/20 | 0.30 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23905254 | 0.89 | POLB (0.32) | LMNATP53ALDH1A1SMN1; SMN2POLB | |
| SCHEMBL23905961 | 0.85 | MAPT (0.32) | TP53 | |
| SCHEMBL23905694 | 0.84 | GABRA5 (0.31) | LMNATP53ABCB1ABCC1GABRA5 | |
| SCHEMBL23905633 | 0.84 | GABRA5 (0.31) | LMNATP53ABCB1ABCC1GABRA5 | |
| SCHEMBL23905318 | 0.84 | GABRA5 (0.32) | GABRA5 | |
| SCHEMBL23904795 | 0.84 | GABRA5 (0.32) | GABRA5 | |
| SCHEMBL23905869 | 0.83 | GABRA5 (0.32) | LMNATP53ALDH1A1SMN1; SMN2P2RX7 | |
| SCHEMBL23905959 | 0.82 | MAPT (0.34) | TP53POLB | |
| SCHEMBL23905782 | 0.81 | POLB (0.32) | ALDH1A1SMN1; SMN2POLBKMT2A | |
| SCHEMBL23905547 | 0.80 | LMNA (0.32) | LMNATP53ALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021198981-A1 | ANTIVIRAL COMPOUNDS AND USES THEREOF | Janssen Biopharma, Inc. (US) | 2021-10-07 | — | — | WO | disclosed |